Results 61 to 70 of about 20,554 (221)

Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates

Journal of Pharmacy and Bioallied Sciences, 2019
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and mortality.
Syed Arman Rabbani, Sathvik B Sridhar, Padma G M Rao, Martin T Kurian, Basset E Essawy   +4 more
doaj   +1 more source

Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial

BMC Nephrology, 2021
Background Hyperphosphatemia is a common complication in patients on maintenance hemodialysis. Patients’ adherence to phosphorus control can be improved by consistent education.
Jinmei Yin, Jun Yin, Rongli Lian, Peiqiu Li, Jing Zheng   +4 more
doaj   +1 more source

Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation [PDF]

, 2016
Pseudohypoparathyroidism type 1b (PHP1b) is characterized by hypocalcemia, hyperphosphatemia, increased levels of circulating parathyroid hormone (PTH), and no skeletal or developmental abnormalities.
Almeida, MR, Batista, S, Brás, J, Guerreiro, R, Hardy, J, Oliveira, C, Pires, P, Ribeiro, MH, Santana, I   +8 more
core   +1 more source

Acceptance and Preference of a Commercial Dry Renal Diet in Healthy Cats: An In‐Home Proof‐of‐Concept Trial

Journal of Animal Physiology and Animal Nutrition, EarlyView.
ABSTRACT Cats diagnosed with chronic kidney disease (CKD) have shown a better prognosis when consuming an appropriate renal diet, which makes its palatability a key factor in ensuring proper compliance. A proof‐of‐concept trial with a commercial dry renal diet was conducted in 33 healthy cats to assess its palatability over three consecutive 6‐day ...
Tomás Rodrigues Magalhães, Ronald Jan Corbee, Felisbina Luísa Queiroga, Ana Luísa Lourenço   +3 more
wiley   +1 more source

Phosphate

Journal of Pediatric Critical Care, 2019
Phosphate plays an important role in cell structure and metabolism. Less than 1% of phosphate is in circulating serum and maintained within narrow range by hormones PTH, calcitonin, FGF23, vitamin D.
Kundan Mittal
doaj   +1 more source

The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: A double blind randomized clinical trial [PDF]

, 2012
Aim The majority of hemodialysis patients are hyperphosphate-mic. Hyperphosphatemia in these patients can lead to renal oste-odystrophy, vascular calcifcation, cardiovascular events, and is independently associated with mortality risk.
Aarabi, M., Baradari, A.G., Espahbodi, F., Zeydi, A.E.   +3 more
core  

Infection with the Neorickettsial Organism Stellantchasmus falcatus Agent in an Arctic Fox (Vulpes lagopus)

Veterinary Clinical Pathology, EarlyView.
ABSTRACT A 1‐year‐old female‐intact arctic fox (Vulpes lagopus) presented for diarrhea, lethargy, severe thrombocytopenia, and hyperbilirubinemia. Blood film evaluation revealed intracytoplasmic coccoid bacteria within moderate numbers of leukocytes consistent with infection by a rickettsial organism.
Jeremy P. Bessett, Alexis G. Davidson, Alyssa M. Scagnelli, Kristen R. Friedrichs   +3 more
wiley   +1 more source

Research status of dietary nursing intervention of hyperphosphatemia in hemodialysis patients (血液透析患者高磷血症饮食护理干预的研究现状)

中西医结合护理, 2021
Hemodialysis patients are prone to hyperphosphatemia in the process of disease progression, which seriously reduce the patient’s quality of life. In clinical treatment and nursing, dietary nursing intervention can improve the prevention awareness of ...
WANG Liwei (王丽伟), LIU Lin (刘玲), YANG Yufei (杨寓斐), E Haiyan (鄂海燕), TANG Ling (唐玲)   +4 more
doaj   +1 more source

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

Therapeutic Apheresis and Dialysis, Volume 30, Issue 3, Page 309-322, June 2026.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa, Daisuke Honda, Seigo Akari, Tadao Akizawa   +3 more
wiley   +1 more source

Investigation of Some Clinicopathologic Alterations in Cats Infected With Mycoplasma haemofelis and Candidatus Mycoplasma haemominutum in Mashhad, Iran: An Observational Cross‐Sectional Study

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
This study detected Mycoplasma haemofelis (34.78%) and Candidatus M. haemominutum (65.21%) in 23% of Iranian cats via PCR. Infection correlated with age, gender and outdoor access (*p < 0.05), causing significant hematologic/biochemical changes. No inter‐species differences in clinical presentation emerged between Mhf and CMhm. ABSTRACT Background Data
Esmaeel Shahtahmasbi, Elham Valavi, Gholam Reza Razmi, Mahdieh Zaeemi   +3 more
wiley   +1 more source